Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Biological Therapy|September 23, 2024
Unmet needs in cervical cancer - can biological therapies plug the gap?Michelle Greenman, Yifan Emily Chang, Blair McNamara, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|November 8, 2017
"I Just Don't Know": An Exploration of Women's Ambivalence about a New PregnancyAbigail Cutler, Blair McNamara, Neena Qasba, et al.
Gynecologic Oncology Reports|June 16, 2023
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapyBlair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Patient Education and Counseling|July 8, 2018
Decision satisfaction among women choosing a method of pregnancy termination in the setting of fetal anomalies and other pregnancy complications: A qualitative studyJennifer L Kerns, Alexis Light, Vanessa Dalton, et al.
Gynecologic Oncology Reports|June 16, 2023
Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapyBlair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Cancers|November 11, 2022
Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive OutcomesLevent Mutlu, Diego D Manavella, Giuseppe Gullo, et al.
Hispanic Health Care International : the Official Journal of the National Association of Hispanic Nurses|September 14, 2021
"Un abrazo a la distancia": An Exploration of Spanish-Speaking Women's Experiences with Pregnancy and Social Isolation in an Urban U.S. SettingTalia Robledo-Gil, Shakkaura Kemet, Meredith Pensak, et al.
Gynecologic Oncology Reports|October 14, 2021
Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancerBlair McNamara, Rosa Guerra, Jennifer Qin, et al.
Gynecologic Oncology Reports|October 31, 2025
Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer caseYasmin Abozenah, Blair McNamara, Michelle Greenman, et al.
Gynecologic Oncology|September 4, 2025
Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenograftsVictoria M Ettorre, Cem Demirkiran, Stefania Bellone, et al.
Pageof 5